Homotaurine in Parkinson's disease. (Q34669429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Homotaurine in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Alfonso Fasano

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Lucia Ricciardi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Alessandro Specchia

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

19 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

published in

Neurological Sciences

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

1581-1587

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Incidence and remaining lifetime risk of Parkinson disease in advanced age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

The source of the memory impairment in Parkinson's disease: acquisition versus retrieval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Cross-cultural evaluation of the short form 8-item Parkinson's Disease Questionnaire (PDQ-8): results from America, Canada, Japan, Italy and Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Normative data for the Montreal Cognitive Assessment in an Italian population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Pedunculopontine nucleus stimulation in Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Studies of interference in serial verbal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

The Multiple Features Target Cancellation (MFTC): an attentional visual conjunction search test. Normative values for the Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Normal sleep homeostasis and lack of epilepsy phenotype in GABA A receptor alpha3 subunit-knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Validity, sensitivity and specificity of the mentation, behavior and mood subscale of the UPDRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2201-6

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

21 January 2018

1 reference

12 December 2020

Construction of freezing of gait questionnaire for patients with Parkinsonism

1 reference

12 December 2020

Recognition memory impairment in Parkinson's disease: power and meta-analyses.

1 reference

12 December 2020

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

12 December 2020

The potential protective effect of tramiprosate (homotaurine) against Alzheimer's disease: a review

1 reference

12 December 2020

Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals

1 reference

12 December 2020

10.1007/S10072-015-2201-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25894843%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference